Atea Pharmaceuticals, Inc. (AVIR)
↓ Download CSV- Sector Manufacturing
- Incorporated MA
- Fiscal year ends Dec 31
Key ratios (FY2025)
-57.5%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | $351.37M | $48.63M | — | — | — |
| Operating Income | -$180.89M | -$192.95M | -$164.16M | -$130.65M | $138.38M | -$11.03M | -$14.61M | -$9.48M | — |
| Net Income | -$158.35M | -$168.38M | -$135.96M | -$115.91M | $121.19M | -$10.95M | -$14.03M | -$9.06M | — |
| EPS (Diluted) | $-1.94 | $-2.00 | $-1.63 | $-1.39 | $1.37 | $-0.51 | $-1.39 | — | — |
| Total Assets | $315.22M | $464.67M | $594.97M | $666.71M | $772.89M | $863.63M | $22.07M | — | — |
| Total Liabilities | $39.78M | $25.80M | $39.78M | $26.14M | $62.81M | $315.83M | $2.53M | — | — |
| Shareholders' Equity | $275.43M | $438.87M | $555.19M | $640.57M | $710.08M | $547.80M | -$49.57M | -$36.16M | -$27.51M |
| Cash & Equivalents | $95.71M | $64.70M | $143.82M | $188.46M | $764.38M | $850.12M | $21.66M | $34.49M | — |
| Operating Cash Flow | -$132.03M | -$135.50M | -$85.39M | -$120.98M | -$87.00M | $296.73M | -$12.83M | -$7.91M | — |
| Capital Expenditures | — | — | — | $1.94M | $4.0K | $26.0K | $2.0K | $12.0K | — |
| Shares Outstanding | 78.13M | 84.46M | 83.44M | 83.29M | 83.10M | 82.44M | 10.09M | — | — |